You are here: Industry Insights > COVID-19

News List

US NIH to launch international alliance for Covid-19 drugs and vaccine pharmaceutical-technology
April 21, 2020
The US National Institutes of Health (NIH) is set to launch a public-private partnership, which will bring together health agencies and pharmaceutical companies to accelerate Covid-19 drugs and vaccines.
Gilead’s remdesivir prevents Covid-19 progression in preclinical study pharmaceutical-technology
April 21, 2020
A preclinical study in the US found that Gilead Sciences’ antiviral drug candidate remdesivir prevented disease progression in rhesus macaques monkeys with Covid-19.
COVID-19 Update: Serological Test Efforts contractpharma
April 21, 2020
The following is a summary comments attributed to Commissioner of Food and Drugs - Food and Drug Administration, Stephen M. Hahn, M.D.
FDA COVID-19 Update contractpharma
April 21, 2020
Public-private partnership with the FDA and others aims to speed the development of COVID-19 vaccine and treatment options.
4D Pharma Begins Phase II COVID-19 Study contractpharma
April 21, 2020
MRx-4DP0004, an immunomodulatory therapy, has shown potential to down-regulate hyper-inflammatory response while maintaining anti-viral response.
Oral Anti-Viral for Covid-19 Filed under FDA’s CTAP contractpharma
April 21, 2020
BioSig’s Vicromax is an orally administered drug that could be delivered to patients during all stages of Covid-19.
Government forms high-level task force for COVID-19-related works expresspharma
April 21, 2020
The task force will ensure work progress in the fields of science and vaccine development.
DBT and BIRAC recommend 16 proposals for funding support towards COVID-19 Research Consortium expresspharma
April 21, 2020
In the wake of the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC) inviting applications on COVID-19 Research Consortium, around 500 applications were received from academia and industry.
Clinical trials on zinc usage initiated for treatment of patients with severe symptoms of COVID-19 expresspharma
April 21, 2020
Zinc is proven to be effective at slowing the rate that similar viruses such as SARS and common cold replicate in the body.
Nationwide launch for GP-based trial of COVID-19 therapies pharmatimes
April 20, 2020
As of this morning – Monday April 20 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 120,067 with 16,060 deaths.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page